Product Code: 26EL-630-4035
Please note: This is a Single Viewer registration for one participant for the on-demand version of this program. Access instructions for the on-demand version of this program will be provided via email approximately 3-10 business days after the live program has occurred and the on-demand version is available. If registering after the on-demand version is available, immediate access is granted via the AABB Education Platform at https://education.aabb.org.
If you registered for the live program you do not need to register for this on-demand eCast (access to the on-demand eCast was included with the live program registration).
If you are interested in presenting this program to a group, please see the “eCast Registration Form– Group Viewing” form on the program page.
Program Description: This program will introduce the subject and concepts behind pathogen-reduction technology applied to transfused red blood cell products (RBCs). The discussion will be centered around their use as part of the Red Cell Pathogen Inactivation (ReCePi) study, a multicenter initiative that investigated the safety and efficacy of pathogen-reduced RBCs in specific clinical settings, and the conclusions of its early investigations. With this context, currently ongoing and potential future applications for these blood products will be discussed.
